{
  "type": "hyp",
  "text": "To correlate changes in nuclear factor binding in vitro with transcriptional activity in vivo and define the structural requirements for IL-2 promoter repression we used transient DNA transfections.\n",
  "self": {
    "NER": {
      "answers": [
        "vivo",
        "IL-2"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "In what way did the IL-2 promoter repression change?",
          "What promoter repression is required for a cell to be able to respond to"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "changes",
        "nuclear factor",
        "transcriptional activity",
        "vivo",
        "the structural requirements",
        "IL-2 promoter repression",
        "we",
        "transient DNA transfections"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What did we use to correlate nuclear factor binding in vitro with transcriptional activity in viv",
          "What binding did we use in vitro?",
          "What did we use to correlate changes in nuclear factor binding in vitro with?",
          "In what way did the IL-2 promoter repression change?",
          "What did the study use to define?",
          "What is the structural requirement for?",
          "What was the purpose of using transient DNA transfections?",
          "What was used to determine the structural requirements for IL-2 promoter repression?"
        ]
      }
    }
  },
  "asked": {
    "What binding to kappa B elements can be blocked by cyclosporin A": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.009619951248168945,
        "ground_truth": {
          "Inducible nuclear factor": {
            "bertscore": 0.6744493842124939,
            "f1": 0
          }
        }
      }
    },
    "What does cyclosporin A block?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0009903907775878906,
        "ground_truth": {
          "the kappa B elements": {
            "bertscore": 0.6423337459564209,
            "f1": 0
          }
        }
      }
    },
    "What is cyclosporin A used to block?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0007992386817932129,
        "ground_truth": {
          "the human immunodeficiency virus enhancer": {
            "bertscore": 0.5872154831886292,
            "f1": 0
          }
        }
      }
    },
    "What type of cells can be blocked by cyclosporin A?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.00010132789611816406,
        "ground_truth": {
          "T cells": {
            "bertscore": 0.6607831716537476,
            "f1": 0
          }
        }
      }
    },
    "What can block inducible nuclear factor binding to kappa B elements?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0044509172439575195,
        "ground_truth": {
          "cyclosporin A": {
            "bertscore": 0.6043254137039185,
            "f1": 0
          }
        }
      }
    },
    "How is cyclosporin A used to block inducible nuclear factor binding?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0010728240013122559,
        "ground_truth": {
          "a signal-dependent manner": {
            "bertscore": 0.6631180644035339,
            "f1": 0
          }
        }
      }
    }
  }
}